LPL Financial’s Tango Therapeutics TNGX Stock Holding History

LPL Financial’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,000	Closed	-$106K	–	6160
2025 Q4	$106K	Buy	+12,000	New	+$103K	﹤0.01%	5581

Other funds holding TNGX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

LPL Financial's TNGX Position: Q1 2026 in Review

LPL Financial sold out of Tango Therapeutics (TNGX) in Q1 2026, closing a stake of 12,000 shares — an estimated $106K sold.

LPL Financial first reported a position in TNGX in Q4 2025 and held it in 1 quarter. The position peaked at $106K in Q4 2025. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

LPL Financial reported no remaining Tango Therapeutics position as of Q1 2026 after selling out during the quarter.
LPL Financial sold 12,000 Tango Therapeutics shares in Q1 2026, an estimated $106K.
LPL Financial first reported a position in Tango Therapeutics in Q4 2025 and held it in 1 quarter.
LPL Financial's Tango Therapeutics position peaked at $106K in Q4 2025.
194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.